JP2022519317A5 - - Google Patents
Info
- Publication number
- JP2022519317A5 JP2022519317A5 JP2021545964A JP2021545964A JP2022519317A5 JP 2022519317 A5 JP2022519317 A5 JP 2022519317A5 JP 2021545964 A JP2021545964 A JP 2021545964A JP 2021545964 A JP2021545964 A JP 2021545964A JP 2022519317 A5 JP2022519317 A5 JP 2022519317A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- compound
- alcohol
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024225026A JP7781250B2 (ja) | 2019-02-06 | 2024-12-20 | 局所ホスホイノシチド3-キナーゼ阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802093P | 2019-02-06 | 2019-02-06 | |
| US62/802,093 | 2019-02-06 | ||
| US202062958049P | 2020-01-07 | 2020-01-07 | |
| US62/958,049 | 2020-01-07 | ||
| PCT/US2020/016876 WO2020163525A1 (en) | 2019-02-06 | 2020-02-05 | Topical phosphoinositide 3-kinase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024225026A Division JP7781250B2 (ja) | 2019-02-06 | 2024-12-20 | 局所ホスホイノシチド3-キナーゼ阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519317A JP2022519317A (ja) | 2022-03-22 |
| JP2022519317A5 true JP2022519317A5 (cg-RX-API-DMAC7.html) | 2023-02-14 |
Family
ID=71835949
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545964A Pending JP2022519317A (ja) | 2019-02-06 | 2020-02-05 | 局所ホスホイノシチド3-キナーゼ阻害剤 |
| JP2024225026A Active JP7781250B2 (ja) | 2019-02-06 | 2024-12-20 | 局所ホスホイノシチド3-キナーゼ阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024225026A Active JP7781250B2 (ja) | 2019-02-06 | 2024-12-20 | 局所ホスホイノシチド3-キナーゼ阻害剤 |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202108274SA (en) | 2019-02-06 | 2021-08-30 | Venthera Inc | Topical phosphoinositide 3-kinase inhibitors |
| EP4192431A1 (en) * | 2020-08-04 | 2023-06-14 | Venthera, Inc. | Formulations of phosphoinositide 3-kinase inhibitors |
| EP4401732A4 (en) * | 2021-09-15 | 2025-09-24 | Dermbiont Inc | COMPOSITIONS AND FORMULATIONS FOR TOPICAL USE OF AN AKT INHIBITOR FOR THE PREVENTION, TREATMENT, AND AMELIORATION OF SKIN DISEASES, CONDITIONS, AND DISORDERS |
| CN115991716B (zh) * | 2021-10-19 | 2025-10-17 | 中国药科大学 | 嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5261001A (en) * | 2000-04-27 | 2001-11-12 | Imperial Cancer Research Technology Ltd | Condensed heteroaryl derivatives |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| JP3602519B2 (ja) | 2002-07-12 | 2004-12-15 | コナミ株式会社 | ビデオゲーム装置、画像処理方法及びプログラム |
| GB0423653D0 (en) | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
| WO2007021933A2 (en) | 2005-08-12 | 2007-02-22 | The General Hospital Corporation | Methods and compositions for use in treating vascular diseases and conditions |
| US8129371B2 (en) * | 2007-10-16 | 2012-03-06 | Wyeth Llc | Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors |
| AU2008335156A1 (en) * | 2007-12-10 | 2009-06-18 | Metaproteomics, Llc | Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith |
| AU2008363813A1 (en) * | 2008-11-07 | 2010-05-14 | Children's Hospital Medical Center | Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems |
| GB2465405A (en) | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| PT2385832E (pt) | 2009-01-08 | 2015-11-02 | Curis Inc | Inibidores de fosfoinoritide 3-quinase com uma fração de ligação ao zinco |
| EP2510121A1 (en) | 2009-12-11 | 2012-10-17 | Wyeth LLC | Phosphatidylinositol-3-kinase pathway biomarkers |
| CN102268014B (zh) | 2010-06-03 | 2015-06-03 | 上海艾力斯医药科技有限公司 | 一类稠合杂芳基衍生物、制备方法及其应用 |
| GB201011771D0 (en) | 2010-07-13 | 2010-08-25 | Bioinvent Int Ab | Biological material and particular uses thereof |
| BR112013008615B1 (pt) | 2010-10-13 | 2021-05-11 | Medivir Ab | composição farmacêutica |
| CN104010494B (zh) | 2011-07-28 | 2017-07-04 | 霍夫曼-拉罗奇有限公司 | Pik3ca h1047r敲入非人动物乳腺癌模型 |
| US8871781B2 (en) | 2011-11-30 | 2014-10-28 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating a subject for a lymphatic malformation |
| CN104379163A (zh) | 2012-06-08 | 2015-02-25 | 霍夫曼-拉罗奇有限公司 | 用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合 |
| WO2014046617A1 (en) | 2012-09-19 | 2014-03-27 | Agency For Science, Technology And Research | Compositions and methods for treating cancer |
| EP3294314A4 (en) | 2015-05-15 | 2019-01-16 | Memorial Sloan Kettering Cancer Center | USE OF PHOPHOINOSITIDE-3-KINASE INHIBITORS FOR THE TREATMENT OF VASCULAR DISEASES |
| JP7051693B2 (ja) | 2016-02-19 | 2022-04-11 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | PIK3CA関連過成長症候群(PROS CLOVaS症候群)の処置に使用するためのBYL719(アルペリシブ) |
| EP3251657A1 (en) | 2016-05-30 | 2017-12-06 | Sun Pharmaceutical Industries Limited | Topical aqueous spray compositions of halobetasol |
| ES2893527T3 (es) | 2016-12-28 | 2022-02-09 | Hisamitsu Pharmaceutical Co | Parche |
| SG11202108274SA (en) | 2019-02-06 | 2021-08-30 | Venthera Inc | Topical phosphoinositide 3-kinase inhibitors |
| EP4192431A1 (en) | 2020-08-04 | 2023-06-14 | Venthera, Inc. | Formulations of phosphoinositide 3-kinase inhibitors |
-
2020
- 2020-02-05 SG SG11202108274SA patent/SG11202108274SA/en unknown
- 2020-02-05 IL IL285020A patent/IL285020B2/en unknown
- 2020-02-05 MA MA054907A patent/MA54907A/fr unknown
- 2020-02-05 MX MX2021009142A patent/MX2021009142A/es unknown
- 2020-02-05 CN CN202080027395.8A patent/CN114072144A/zh active Pending
- 2020-02-05 AU AU2020219065A patent/AU2020219065A1/en not_active Abandoned
- 2020-02-05 JP JP2021545964A patent/JP2022519317A/ja active Pending
- 2020-02-05 BR BR112021015353-5A patent/BR112021015353A2/pt unknown
- 2020-02-05 KR KR1020217027706A patent/KR20210124310A/ko not_active Ceased
- 2020-02-05 WO PCT/US2020/016876 patent/WO2020163525A1/en not_active Ceased
- 2020-02-05 EP EP20752673.2A patent/EP3920911A4/en active Pending
- 2020-02-05 US US16/783,050 patent/US11661429B2/en active Active
- 2020-02-06 TW TW109103710A patent/TWI862548B/zh active
-
2021
- 2021-08-05 SA SA521422728A patent/SA521422728B1/ar unknown
- 2021-08-05 SA SA522441650A patent/SA522441650B1/ar unknown
-
2023
- 2023-04-10 US US18/297,698 patent/US12522614B2/en active Active
-
2024
- 2024-12-20 JP JP2024225026A patent/JP7781250B2/ja active Active